MINERVA UROL NEFROL 润色咨询

Minerva Urologica E Nefrologica

出版年份：暂无数据 年文章数：38 投稿命中率： 开通期刊会员，数据随心看

出版周期：Quarterly 自引率：38.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2092598, encodeId=5c482092598b9, content=更名为Minerva Urology and Nephrology，影响因子5.214, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c32b5554237, createdName=ms5000000156787776, createdTime=Sun Oct 09 00:30:16 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105075, encodeId=827011050e508, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105076, encodeId=f29d11050e6f6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897596, encodeId=294689e596a0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：泌尿外科<br>经验分享：1月份投稿，5月返修，10月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06fa1602558, createdName=136196db5bm, createdTime=Sat Nov 07 18:39:38 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895156, encodeId=2c5b89515614, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2月份开始投，四月中返修，五月底接受，不知道是不是疫情影响，迟迟没有proof,现在已经快十一月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07b2381207, createdName=urodeng_52465679, createdTime=Wed Oct 28 20:05:13 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2022-10-09 ms5000000156787776

    更名为Minerva Urology and Nephrology，影响因子5.214

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2092598, encodeId=5c482092598b9, content=更名为Minerva Urology and Nephrology，影响因子5.214, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c32b5554237, createdName=ms5000000156787776, createdTime=Sun Oct 09 00:30:16 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105075, encodeId=827011050e508, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105076, encodeId=f29d11050e6f6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897596, encodeId=294689e596a0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：泌尿外科<br>经验分享：1月份投稿，5月返修，10月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06fa1602558, createdName=136196db5bm, createdTime=Sat Nov 07 18:39:38 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895156, encodeId=2c5b89515614, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2月份开始投，四月中返修，五月底接受，不知道是不是疫情影响，迟迟没有proof,现在已经快十一月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07b2381207, createdName=urodeng_52465679, createdTime=Wed Oct 28 20:05:13 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2021-12-29 衣谷

    如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2092598, encodeId=5c482092598b9, content=更名为Minerva Urology and Nephrology，影响因子5.214, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c32b5554237, createdName=ms5000000156787776, createdTime=Sun Oct 09 00:30:16 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105075, encodeId=827011050e508, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105076, encodeId=f29d11050e6f6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897596, encodeId=294689e596a0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：泌尿外科<br>经验分享：1月份投稿，5月返修，10月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06fa1602558, createdName=136196db5bm, createdTime=Sat Nov 07 18:39:38 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895156, encodeId=2c5b89515614, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2月份开始投，四月中返修，五月底接受，不知道是不是疫情影响，迟迟没有proof,现在已经快十一月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07b2381207, createdName=urodeng_52465679, createdTime=Wed Oct 28 20:05:13 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2021-12-28 Mia

    我的结果太多了，文章放不下，应该怎么处理？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2092598, encodeId=5c482092598b9, content=更名为Minerva Urology and Nephrology，影响因子5.214, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c32b5554237, createdName=ms5000000156787776, createdTime=Sun Oct 09 00:30:16 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105075, encodeId=827011050e508, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105076, encodeId=f29d11050e6f6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897596, encodeId=294689e596a0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：泌尿外科<br>经验分享：1月份投稿，5月返修，10月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06fa1602558, createdName=136196db5bm, createdTime=Sat Nov 07 18:39:38 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895156, encodeId=2c5b89515614, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2月份开始投，四月中返修，五月底接受，不知道是不是疫情影响，迟迟没有proof,现在已经快十一月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07b2381207, createdName=urodeng_52465679, createdTime=Wed Oct 28 20:05:13 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-11-07 136196db5bm

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：泌尿外科
    经验分享：1月份投稿，5月返修，10月接收。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2092598, encodeId=5c482092598b9, content=更名为Minerva Urology and Nephrology，影响因子5.214, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c32b5554237, createdName=ms5000000156787776, createdTime=Sun Oct 09 00:30:16 CST 2022, time=2022-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105075, encodeId=827011050e508, content=如果我图片太多/表格太多超出了期刊要求的数目，应该如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1105076, encodeId=f29d11050e6f6, content=我的结果太多了，文章放不下，应该怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897596, encodeId=294689e596a0, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：泌尿外科<br>经验分享：1月份投稿，5月返修，10月接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=06fa1602558, createdName=136196db5bm, createdTime=Sat Nov 07 18:39:38 CST 2020, time=2020-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=895156, encodeId=2c5b89515614, content=审稿速度:3.0 | 投稿命中率:50.0<br>经验分享：2月份开始投，四月中返修，五月底接受，不知道是不是疫情影响，迟迟没有proof,现在已经快十一月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f07b2381207, createdName=urodeng_52465679, createdTime=Wed Oct 28 20:05:13 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 urodeng_52465679

    审稿速度:3.0 | 投稿命中率:50.0
    经验分享：2月份开始投，四月中返修，五月底接受，不知道是不是疫情影响，迟迟没有proof,现在已经快十一月了

    0

共7条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分